Federated Hermes
IDYA icon

Federated Hermes’s IDEAYA Biosciences IDYA Stock Holding History

Federated Hermes’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.4M Sell
1,431,630
-1,555,477
-52% -$47.6M 0.08% 259
2026
Q1 		$99.5M Sell
2,987,107
-408,664
-12% -$13.7M 0.16% 141
2025
Q4 		$117M Sell
3,395,771
-1,230,079
-27% -$39.2M 0.2% 123
2025
Q3 		$126M Sell
4,625,850
-1,416
-0% -$34.2K 0.22% 110
2025
Q2 		$97.3M Sell
4,627,266
-140,660
-3% -$2.7M 0.18% 146
2025
Q1 		$78.1M Sell
4,767,926
-295,600
-6% -$6.3M 0.17% 157
2024
Q4 		$130M Sell
5,063,526
-144,774
-3% -$4.1M 0.29% 85
2024
Q3 		$165M Buy
5,208,300
+352,510
+7% +$13.4M 0.36% 57
2024
Q2 		$170M Sell
4,855,790
-288
-0% -$11.4K 0.4% 49
2024
Q1 		$213M Buy
4,856,078
+972,303
+25% +$41.8M 0.49% 40
2023
Q4 		$138M Buy
3,883,775
+500,046
+15% +$14.9M 0.34% 61
2023
Q3 		$91.3M Sell
3,383,729
-5,969
-0.2% -$151K 0.24% 93
2023
Q2 		$79.7M Buy
3,389,698
+525,091
+18% +$10.8M 0.2% 114
2023
Q1 		$39.3M Buy
2,864,607
+107
+0% +$1.78K 0.1% 249
2022
Q4 		$52M Buy
2,864,500
+2,409
+0.1% +$40.5K 0.14% 183
2022
Q3 		$42.7M Buy
2,862,091
+700,000
+32% +$9.09M 0.13% 209
2022
Q2 		$29.8M Sell
2,162,091
-87,089
-4% -$969K 0.08% 297
2022
Q1 		$25.2M Sell
2,249,180
-41,102
-2% -$606K 0.06% 388
2021
Q4 		$54.1M Sell
2,290,282
-14,894
-0.6% -$346K 0.1% 262
2021
Q3 		$58.8M Buy
2,305,176
+668,237
+41% +$15.6M 0.11% 244
2021
Q2 		$34.4M Buy
1,636,939
+130,727
+9% +$2.69M 0.06% 360
2021
Q1 		$35.4M Buy
1,506,212
+407,864
+37% +$7.87M 0.07% 357
2020
Q4 		$15.4M Buy
1,098,348
+1,097,266
+101,411% +$14.9M 0.03% 534
2020
Q3 		$14K Buy
+1,082
New +$13.4K ﹤0.01% 1933

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Federated Hermes's IDYA Position: Q2 2026 in Review

Federated Hermes reduced its IDEAYA Biosciences (IDYA) stake by 52% in Q2 2026, selling an estimated $47.6M and leaving 1,431,630 shares worth $53.4M. The position accounts for 0.08% of the portfolio, ranked #259.

Federated Hermes first reported a position in IDYA in Q3 2020 and has held it in 24 quarters since. The position peaked at $213M in Q1 2024. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Federated Hermes held 1,431,630 shares of IDEAYA Biosciences worth $53.4M as of Q2 2026.
  • Federated Hermes sold 1,555,477 IDEAYA Biosciences shares in Q2 2026, an estimated $47.6M.
  • IDEAYA Biosciences made up 0.08% of Federated Hermes's portfolio in Q2 2026, its #259 holding.
  • Federated Hermes first reported a position in IDEAYA Biosciences in Q3 2020 and has held it in 24 quarters since.
  • Federated Hermes's IDEAYA Biosciences position peaked at $213M in Q1 2024.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.